| Programme | |
|---|---|
| Welcome remarks Prof. Dan Yock Young | |
| Session 1 | |
| NASH as a multisystem disorder- review of the evidence – Prof. Arun Sanyal View Bio |
|
| Host determinants on metabolic health and NASH progression – Dr. Mark Muthiah View Bio |
|
| Environmental drivers of end organ disease in NAFLD – Prof. Chan Wah Kheong View Bio |
|
| Discussion – Prof. Tai E Shyong / Prof. Chan Wah Kheong View Bio |
|
| Tea Break | |
| Session 2 | |
| Redefining NASH as a disease of accelerated aging – Prof. Arun Sanyal View Bio |
|
| The clinical / mechanistic basis for the liver-heart connection in NASH – Prof. Shadab Siddiqui View Bio |
|
| Thyroid hormone and NASH – Dr Brijesh Kumar Singh |
|
| Discussion – Dr. Mark Muthiah View Bio / Prof. Chan Wah Kheong View Bio |
|
| Lunch | |
| Session 3 – Controversies | |
| Alcohol is a major confounder in assessment and management of NASH – For the motion: Prof. Ajay Duseja View Bio – Against the motion:: Prof. Chan Wah Kheong View Bio |
|
| Discussion – Prof. Dan Yock Young View Bio / Prof Khin Maung Win |
|
| Break | |
| Session 4 | |
| How to develop and evaluate a NIT – Prof. Arun Sanyal View Bio |
|
| Innovations in histological assessment- what will be the role of histology in NASH – Prof. Arun Sanyal View Bio |
|
| Status of current NITs for risk stratification and disease monitoring for NAFLD and metabolic health – Prof. Vincent Wong View Bio |
|
| Discussion – Prof. Shadab Siddiqui View Bio / Dr. Mark Muthiah View Bio |
|
| Tea Break | |
| Session 5 | |
| Preparing Asia for Precision Medicine for NASH in the context of metabolic health – Prof. Dan Yock Young View Bio |
|
| Current best practises in the NASH patient – Dr. Mark Muthiah View Bio |
|
| Transplanting the decompensated NASH cirrhotic patient – Prof. Shadab Sidiqqui View Bio |
|
| Discussion – Prof. Ajay Duseja View Bio / Prof. Khin Maung Win |
|
| Challenges and Opportunities in NASH- a state of the art – Prof. Arun Sanyal View Bio |
|
